Skip to main content
. 2019 Jul 2;8:e45068. doi: 10.7554/eLife.45068

Table 2. Intracellular concentrations of FBP, Phe and Ser in cancer cell lines.

Metabolite Media condition Cell line [Metabolite]ic (µM) Fractional saturation
FBP Gluc-
(RPMI)
HCT116 38.4 ± 16.6 0.99 ± 0.00
LN229 73.4 ± 18.4 0.99 ± 0.00
SN12C 19.9 ± 7.5 0.98 ± 0.00
Gluc+
(RPMI)
HCT116 238.4 ± 67.4 0.99 ± 0.00
LN229 302.0 ± 75.3 0.99 ± 0.00
SN12C 355.1 ± 66.2 0.99 ± 0.00
Gluc+ aa-
(HBSS)
HCT116 337.2 ± 185.5 0.99 ± 0.00
LN229 257.0 ± 33.9 0.99 ± 0.00
SN12C 236.8 ± 41.1 0.99 ± 0.00
Gluc+ Phe500 Ser100
(HBSS)
HCT116 384.5 ± 41.8 0.99 ± 0.00
LN229 277.3 ± 83.4 0.99 ± 0.00
SN12C 300.3 ± 89.1 0.99 ± 0.00
Gluc+ Phe100 Ser500
(HBSS)
HCT116 400.9 ± 82.2 0.99 ± 0.00
LN229 372.2 ± 106.0 0.99 ± 0.00
SN12C 286.4 ± 73.6 0.99 ± 0.00
Phe Gluc-
(RPMI)
HCT116 256.3 ± 65.8 0.56 ± 0.06
LN229 231.6 ± 22.6 0.55 ± 0.03
SN12C 100.4 ± 24.6 0.34 ± 0.06
Gluc+
(RPMI)
HCT116 258.2 ± 79.6 0.56 ± 0.08
LN229 318.7 ± 115.8 0.61 ± 0.09
SN12C 197.5 ± 26.6 0.51 ± 0.04
Gluc+ aa-
(HBSS)
HCT116 41.1 ± 15.8 0.17 ± 0.05
LN229 31.7 ± 28.0 0.13 ± 0.12
SN12C 10.6 ± 0.6 0.05 ± 0.02
Gluc+ Phe500 Ser100
(HBSS)
HCT116 1776.2 ± 225.1 0.90 ± 0.01
LN229 1666.5 ± 543.0 0.89 ± 0.04
SN12C 926.1 ± 252.7 0.82 ± 0.04
Gluc+ Phe100 Ser500
(HBSS)
HCT116 582.4 ± 23.8 0.75 ± 0.01
LN229 575.7 ± 224.4 0.73 ± 0.11
SN12C 221.6 ± 49.1 0.53 ± 0.06
Ser Gluc-
(RPMI)
HCT116 3580.9 ± 1016.9 0.87 ± 0.03
LN229 1755.0 ± 159.5 0.77 ± 0.02
SN12C 854.3 ± 240.7 0.62 ± 0.07
Gluc+
(RPMI)
HCT116 3943.5 ± 1363.1 0.88 ± 0.05
LN229 2226.7 ± 757.7 0.80 ± 0.06
SN12C 1766.0 ± 142.9 0.78 ± 0.01
Gluc+ aa-
(HBSS)
HCT116 426.9 ± 179.2 0.44 ± 0.09
LN229 249.6 ± 221.8 0.28 ± 0.25
SN12C 111.0 ± 18.4 0.18 ± 0.02
Gluc+ Phe500 Ser100
(HBSS)
HCT116 6157.3 ± 1334.4 0.92 ± 0.01
LN229 2641.1 ± 825.1 0.83 ± 0.06
SN12C 2197.7 ± 605.8 0.81 ± 0.04
Gluc+ Phe100 Ser500
(HBSS)
HCT116 22360.4 ± 1554.2 0.98 ± 0.00
LN229 8464.7 ± 3214.5 0.93 ± 0.04
SN12C 6603.9 ± 1500.4 0.93 ± 0.02